These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 11872874

  • 1. Major improvements in cost effectiveness of screening women for Chlamydia trachomatis using pooled urine specimens and high performance testing.
    Morré SA, Welte R, Postma MJ.
    Sex Transm Infect; 2002 Feb; 78(1):74-5. PubMed ID: 11872874
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Opportunistic screening for genital infections with Chlamydia trachomatis in sexually active population of Amsterdam. II. Cost-effectiveness analysis of screening women].
    Ruitenberg EN.
    Ned Tijdschr Geneeskd; 1999 May 08; 143(19):1012. PubMed ID: 10368724
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Screening for asymptomatic Chlamydia trachomatis infection in pregnancy; cost-effectiveness favorable at a minimum prevalence rate of 3% or more].
    Postma MJ, Bakker A, Welte R, van Bergen JE, van den Hoek JA, de Jong-van den Berg LT, Jager JC.
    Ned Tijdschr Geneeskd; 2000 Dec 02; 144(49):2350-4. PubMed ID: 11129971
    [Abstract] [Full Text] [Related]

  • 8. A Swedish cost-effectiveness analysis of community-based Chlamydia trachomatis PCR testing of postal urine specimens obtained at home.
    Novak DP, Lindholm L, Jonsson M, Karlsson RB.
    Scand J Public Health; 2004 Dec 02; 32(5):324-32. PubMed ID: 15513664
    [Abstract] [Full Text] [Related]

  • 9. Cost effectiveness analysis of a population based screening programme for asymptomatic Chlamydia trachomatis infections in women by means of home obtained urine specimens.
    van Valkengoed IG, Postma MJ, Morré SA, van den Brule AJ, Meijer CJ, Bouter LM, Boeke AJ.
    Sex Transm Infect; 2001 Aug 02; 77(4):276-82. PubMed ID: 11463928
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Cost-effectiveness analysis of screening adolescent males for Chlamydia on admission to detention.
    Blake DR, Gaydos CA, Quinn TC.
    Sex Transm Dis; 2004 Feb 02; 31(2):85-95. PubMed ID: 14743071
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Health and cost-benefits of chlamydia screening in young women.
    Mangione-Smith R, O'Leary J, McGlynn EA.
    Sex Transm Dis; 1999 Jul 02; 26(6):309-16. PubMed ID: 10417017
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Screening for Chlamydia trachomatis in adolescent males: a cost-based decision analysis.
    Randolph AG, Washington AE.
    Am J Public Health; 1990 May 02; 80(5):545-50. PubMed ID: 2109544
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. An evaluation of economics and acceptability of screening for Chlamydia trachomatis infection, in women attending antenatal, abortion, colposcopy and family planning clinics in Scotland, UK.
    Norman JE, Wu O, Twaddle S, Macmillan S, McMillan L, Templeton A, McKenzie H, Noone A, Allardice G, Reid M.
    BJOG; 2004 Nov 02; 111(11):1261-8. PubMed ID: 15521872
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Potentials of screening for Chlamydia trachomatis in Hungary: cost-benefit analysis].
    Nyári T, Mészáros G, Deák J, Nagy E, Kovács L.
    Orv Hetil; 2000 Jul 02; 141(27):1511-6. PubMed ID: 10943109
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.